NASDAQ: PRVB $950 Million Small-Cap. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 202%. 1 Year Return 9%. 2021 YTD Return 20%. Since Earnings 3%.
The 52 Week Low is $4.72 set on Wed, Mar 18, 2020.
The 52 Week High is $20.05 set on Tue, Jan 12, 2021.
The All-Time High is $20.05 set on Tue, Jan 12, 2021.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Provention Bio Inc trades on the NASDAQ. PRVB's market cap is 950.00 Million.
Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the sourcing, developing and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. The company's pipeline includes PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-101.
For Starters
Track your portfolio and more.
